MYBBP1A
Myb-binding protein 1A
Also known as: FLJ37886, MBB1A_HUMAN, P160, PAP2, Pol5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BQG0
- Gene
- MYBBP1A
- Ensembl
- ENSG00000132382
- Chromosome
- 17
- Canonical length
- 1328 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Vesicles
OverviewNCBI Gene
This gene encodes a nucleolar transcriptional regulator that was first identified by its ability to bind specifically to the Myb proto-oncogene protein. The encoded protein is thought to play a role in many cellular processes including response to nucleolar stress, tumor suppression and synthesis of ribosomal DNA. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
1328 residues, UniProt reviewed canonical sequence.
>Q9BQG0|MYBBP1A
1 MESRDPAQPM SPGEATQSGA RPADRYGLLK HSREFLDFFW DIAKPEQETR LAATEKLLEY
61 LRGRPKGSEM KYALKRLITG LGVGRETARP CYSLALAQLL QSFEDLPLCS ILQQIQEKYD
121 LHQVKKAMLR PALFANLFGV LALFQSGRLV KDQEALMKSV KLLQALAQYQ NHLQEQPRKA
181 LVDILSEVSK ATLQEILPEV LKADLNIILS SPEQLELFLL AQQKVPSKLK KLVGSVNLFS
241 DENVPRLVNV LKMAASSVKK DRKLPAIALD LLRLALKEDK FPRFWKEVVE QGLLKMQFWP
301 ASYLCFRLLG AALPLLTKEQ LHLVMQGDVI RHYGEHVCTA KLPKQFKFAP EMDDYVGTFL
361 EGCQDDPERQ LAVLVAFSSV TNQGLPVTPT FWRVVRFLSP PALQGYVAWL RAMFLQPDLD
421 SLVDFSTNNQ KKAQDSSLHM PERAVFRLRK WIIFRLVSIV DSLHLEMEEA LTEQVARFCL
481 FHSFFVTKKP TSQIPETKHP FSFPLENQAR EAVSSAFFSL LQTLSTQFKQ APGQTQGGQP
541 WTYHLVQFAD LLLNHSHNVT TVTPFTAQQR QAWDRMLQTL KELEAHSAEA RAAAFQHLLL
601 LVGIHLLKSP AESCDLLGDI QTCIRKSLGE KPRRSRTKTI DPQEPPWVEV LVEILLALLA
661 QPSHLMRQVA RSVFGHICSH LTPRALQLIL DVLNPETSED ENDRVVVTDD SDERRLKGAE
721 DKSEEGEDNR SSESEEESEG EESEEEERDG DVDQGFREQL MTVLQAGKAL GGEDSENEEE
781 LGDEAMMALD QSLASLFAEQ KLRIQARRDE KNKLQKEKAL RRDFQIRVLD LVEVLVTKQP
841 ENALVLELLE PLLSIIRRSL RSSSSKQEQD LLHKTARIFT HHLCRARRYC HDLGERAGAL
901 HAQVERLVQQ AGRQPDSPTA LYHFNASLYL LRVLKGNTAE GCVHETQEKQ KAGTDPSHMP
961 TGPQAASCLD LNLVTRVYST ALSSFLTKRN SPLTVPMFLS LFSRHPVLCQ SLLPILVQHI
1021 TGPVRPRHQA CLLLQKTLSM REVRSCFEDP EWKQLMGQVL AKVTENLRVL GEAQTKAQHQ
1081 QALSSLELLN VLFRTCKHEK LTLDLTVLLG VLQGQQQSLQ QGAHSTGSSR LHDLYWQAMK
1141 TLGVQRPKLE KKDAKEIPSA TQSPISKKRK KKGFLPETKK RKKRKSEDGT PAEDGTPAAT
1201 GGSQPPSMGR KKRNRTKAKV PAQANGTPTT KSPAPGAPTR SPSTPAKSPK LQKKNQKPSQ
1261 VNGAPGSPTE PAGQKQHQKA LPKKGVLGKS PLSALARKKA RLSLVIRSPS LLQSGAKKKA
1321 QVRKAGKPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYBBP1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 26 nTPM
- pancreas: 24 nTPM
- skin: 22 nTPM
- salivary gland: 18 nTPM
- esophagus: 17 nTPM
- prostate: 17 nTPM
Single-cell type
- differentiating spermatogonia: 26 nCPM
- esophageal basal cells: 26 nCPM
- erythrocyte progenitors: 24 nCPM
- alveolar cells type 1: 24 nCPM
- oocytes: 23 nCPM
- suprabasal keratinocytes: 23 nCPM
Immune cell
- MAIT T-cell: 3.4 nTPM
- non-classical monocyte: 3.4 nTPM
- memory CD8 T-cell: 3.1 nTPM
- gdT-cell: 2.9 nTPM
- memory B-cell: 2.9 nTPM
- myeloid DC: 2.9 nTPM
Brain region
- cerebral cortex: 29 nTPM
- medulla oblongata: 25 nTPM
- midbrain: 25 nTPM
- hypothalamus: 23 nTPM
- hippocampal formation: 22 nTPM
- pons: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.75
- DepMap mean gene effect
- -0.55
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to glucose starvation
- chromatin remodeling
- circadian regulation of gene expression
- intrinsic apoptotic signaling pathway by p53 class mediator
- negative regulation of DNA-templated transcription
- osteoblast differentiation
- positive regulation of anoikis
- positive regulation of transcription by RNA polymerase I
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase III
- regulation of DNA-templated transcription
- regulation of G1 to G0 transition
- respiratory electron transport chain
- ribosome biogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Armadillo-like helical
- Armadillo-type fold
- DNA polymerase V/Myb-binding protein 1A
- DNA polymerase phi
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MYBBP1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYBBP1A as an antibody target. Whether an autoantibody or antibody against MYBBP1A could matter depends on whether native MYBBP1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYBBP1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYBBP1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...